Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
103.09
Dollar change
-0.46
Percentage change
-0.44
%
IndexDJIA, S&P 500 P/E21.59 EPS (ttm)4.77 Insider Own0.09% Shs Outstand2.53B Perf Week1.43%
Market Cap259.62B Forward P/E10.98 EPS next Y9.39 Insider Trans0.00% Shs Float2.53B Perf Month2.34%
Income12.15B PEG0.77 EPS next Q1.83 Inst Own78.96% Short Float1.04% Perf Quarter-10.67%
Sales62.89B P/S4.13 EPS this Y413.08% Inst Trans0.00% Short Ratio2.48 Perf Half Y-21.11%
Book/sh17.58 P/B5.87 EPS next Y21.22% ROA10.83% Short Interest26.32M Perf Year-2.40%
Cash/sh5.81 P/C17.74 EPS next 5Y28.00% ROE28.33% 52W Range94.48 - 134.63 Perf YTD-5.44%
Dividend Est.3.10 (3.01%) P/FCF17.49 EPS past 5Y-42.70% ROI15.28% 52W High-23.43% Beta0.40
Dividend TTM3.08 (2.99%) Quick Ratio1.15 Sales past 5Y7.72% Gross Margin73.03% 52W Low9.11% ATR (14)2.04
Dividend Ex-DateDec 16, 2024 Current Ratio1.36 EPS Y/Y TTM163.70% Oper. Margin23.00% RSI (14)53.83 Volatility1.64% 2.09%
Employees72000 Debt/Eq0.86 Sales Y/Y TTM8.17% Profit Margin19.32% Recom1.62 Target Price130.22
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q-33.34% Payout2065.60% Rel Volume1.08 Prev Close103.55
Sales Surprise1.11% EPS Surprise5.80% Sales Q/Q4.42% EarningsOct 31 BMO Avg Volume10.63M Price103.09
SMA202.94% SMA50-1.35% SMA200-13.53% Trades Volume11,460,459 Change-0.44%
Date Action Analyst Rating Change Price Target Change
Dec-04-24Upgrade HSBC Securities Hold → Buy $130
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-11-24Downgrade Daiwa Securities Buy → Neutral
Oct-17-24Initiated Bernstein Mkt Perform $115
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Dec-06-24 01:29PM
Dec-05-24 01:45PM
09:00AM
07:48AM
06:45AM
09:25AM Loading…
Dec-04-24 09:25AM
06:50AM
Dec-03-24 03:10PM
06:45AM
Dec-02-24 07:46AM
07:13AM
Nov-26-24 09:11AM
06:50AM
06:45AM
Nov-25-24 12:02PM
06:57AM Loading…
06:57AM
06:45AM
04:22AM
Nov-23-24 10:18AM
10:18AM
06:30AM
Nov-22-24 04:17PM
09:00AM
07:15AM
06:45AM
06:30AM
06:19AM
06:03AM
Nov-21-24 06:45AM
02:12AM
03:10PM Loading…
Nov-20-24 03:10PM
02:14PM
Nov-19-24 01:17PM
12:22PM
06:47AM
06:45AM
Nov-18-24 06:00PM
09:49AM
02:53AM
12:44AM
Nov-15-24 04:18PM
09:43AM
07:15AM
Nov-14-24 04:54PM
07:15AM
06:45AM
05:39AM
Nov-13-24 06:56AM
05:26AM
Nov-12-24 06:45AM
03:00AM
Nov-09-24 10:41AM
Nov-08-24 02:47PM
11:23AM
09:36AM
09:00AM
Nov-07-24 10:36AM
07:00AM
Nov-06-24 06:45AM
Nov-04-24 06:41PM
Nov-01-24 02:33PM
03:08AM
01:55AM
Oct-31-24 04:12PM
02:03PM
01:15PM
10:03AM
07:09AM
06:37AM
06:35AM
06:30AM
06:30AM
Oct-30-24 12:44PM
01:29AM
Oct-28-24 12:45PM
06:45AM
Oct-27-24 08:58AM
01:39AM
Oct-25-24 06:47PM
04:15PM
Oct-24-24 02:46PM
01:42PM
01:25PM
10:01AM
09:00AM
06:45AM
Oct-23-24 07:58PM
03:35PM
10:06AM
07:45AM
Oct-22-24 05:50PM
Oct-21-24 12:28PM
Oct-20-24 03:00PM
Oct-19-24 05:09PM
11:57AM
Oct-18-24 04:46PM
03:25PM
08:08AM
03:20AM
Oct-17-24 06:34PM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guindo ChirfiChief Marketing OfficerAug 05 '24Option Exercise115.2036,9014,250,99557,782Aug 06 12:20 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM